Furthermore, high expression of SLAMF6 is associated with the elevation of anti-cancer immune response represented by the enrichment of gene sets associated with proinflammatory, IFN-γ and T-cell response, and improved survival in patients with breast cancer and melanoma. The gene discussed is IFNG; the disease is melanoma.